United StatesÚltimas notícias

BeOne Medicines (NASDAQ:ONC) announced positive topline results from the Phase 3 MANGROVE study evaluating BRUKINSA plus rituximab versus bendamustine plus rituximab in adult patients with previously untreated mantle cell lymphoma.

The time between a software vulnerability being found and then exploited by a bad actor is shrinking says Tobias Adrian, Financial Counsellor and Director of the Monetary and Capital Markets Department at the International Monetary Fund. This poses a real threat to financial stability, says Adrian. He spoke to Bloomberg's Francine Lacqua on the sidelines of the ECB Forum on Central Banking in Sintra on 'The Pulse'.

Former Goldman Sachs economist Jim O'Neill, who has advised UK leadership contender Andy Burnham on economic matters, discusses the Labour Party MP's plan to decentralize power in a bid to boost Britain's economy. O'Neill speaks on Bloomberg Television.

Britain’s competition regulator proposed allowing app developers to steer users to alternative payment options outside Apple and Google app stores to reduce fees and boost competition.

Nike (NYSE:NKE) reported fourth quarter fiscal 2026 revenue of $11 billion, down 1% on a reported basis and down 4% on a currency-neutral basis.

Intrusion (NASDAQ:INTZ) said it has completed its acquisition of VigilAigent, a managed security service provider previously owned by Tego Cyber.

Progress Software (NASDAQ:PRGS) reported second quarter fiscal 2026 revenue of $253 million, an increase of 7% year over year on an actual currency basis and 6% on a constant currency basis.

Anna Edwards, Guy Johnson, Tom Mackenzie and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Innovent Biologics and Lilly (NYSE:LLY) entered a commercialization agreement for Verzenios (abemaciclib) in mainland China, shifting commercial control to Innovent.

Fabiana Fedeli, CIO of multi-asset at M&G Investments, says that while there is still value in equities, markets such as South Korea have displayed "exuberant" behavior. Speaking on Bloomberg Television, she says: "there is a whole host of stocks which are the AI losers the stocks that have been forgotten by the AI trade that I still think I still think are very worthwhile investing in."

Hafnia (NYSE:HAFN) said Chief Executive Officer Mikael Skov will step down on 1 September 2026, with EVP Søren Steenberg Jensen appointed as his successor.

Evotec (NASDAQ:EVO) launched J.TRAIN, a turnkey biologics manufacturing model designed to place its continuous manufacturing technology inside partner-owned facilities.